Oral Mucositis (Ulcerative) Due to Radiation Clinical Trial
Official title:
A Phase 3, Open Label, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Efficacy of Ulinastatin in the Reduction of Acute Oral Mucositis Caused by Concurrent Chemoradiotherapy(CCRT) for Patients With Localregionally Advanced Nasopharyngeal Carcinoma (NPC).
This is a phase 3, open-label, multicenter, randomized controlled phase III clinical trial. The purpose of this study is to evaluate the efficacy of ulinastatin, a kind of protease inhibitor, in the treatment of radiation-induced acute oral mucositis in localregionally advanced nasopharyngeal carcinoma(NPC) patients treated with concurrent chemoradiotherapy(CCRT). To Explore a new and efficient way to reduce the incidence and severity of radiation-induced acute oral mucositis.
Radiation-induced acute oral mucositis (RTOM) in Nasopharyngeal Carcinoma (NPC) patients treat with concurrent chemoradiotherapy (CCRT) is common. Currently, there is no effective treatment for RTOM. Ulinastatin, is a kind of natural anti-inflammatory substance. And this substance is insufficient when the body's inflammatory response is strongly. There are a series of studies have confirmed the efficacy and safety of ulinastatin in the treatment of body's inflammatory response. From the observation of our previous clinical practice, we found that ulinastatin can relieve the severity of RTOM. The present study is undertaken to evaluate the efficacy of ulinastatin in the treatment of RTOM in localregionally advanced NPC patients treated with CCRT. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01318889 -
Dexpanthenol Mouthwash to Treat Oral Mucositis
|
Phase 2 | |
Recruiting |
NCT06285591 -
Lactobacillus Reuteri Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors
|
N/A | |
Completed |
NCT04699487 -
Efficacy and Safety of CareMin650 for Prevention of Oral Mucositis in HNC Patients Starting Radiotherapy
|
N/A | |
Not yet recruiting |
NCT05664906 -
Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients
|
Phase 1/Phase 2 | |
Completed |
NCT03833570 -
Melatonin for Prevention of Radiation Induced Oral Mucositis
|
Phase 2 | |
Recruiting |
NCT05322421 -
Effectiveness of Topical Olive Oil in Prevention and Management of Radiation Induced Oral Mucositis
|
N/A | |
Active, not recruiting |
NCT03972527 -
Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients
|
N/A | |
Recruiting |
NCT06354712 -
Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.
|
Phase 2 |